Education
About Us
Working with TipRanks
Follow Us
Stella Diagnostics (SLDX)
OTHER OTC:SLDX
Total Valuation
Stella Diagnostics has a market cap or net worth of $4.52M. The enterprise value is $21.16M.
Market Cap$4.52M
Enterprise Value$21.16M
Share Statistics
Stella Diagnostics has 97,550,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding97,550,650
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Stella Diagnostics’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 8.37%.
Return on Equity (ROE)0.07
Return on Assets (ROA)-6.53
Return on Invested Capital (ROIC)8.37%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee0.00
Profits Per Employee-617.83K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Stella Diagnostics is -13.98. Stella Diagnostics’s PEG ratio is 0.03.
PE Ratio-13.98
PS Ratio0.00
PB Ratio-0.60
Price to Fair Value-0.92
Price to FCF-49.20
Price to Operating Cash Flow-49.20
PEG Ratio0.03
Income Statement
In the last 12 months, Stella Diagnostics had revenue of 0.00 and earned -1.24M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-1.01M
Pretax Income-1.24M
Net Income-1.24M
EBITDA-1.24M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -57.74K and capital expenditures -4.00, giving a free cash flow of -57.74K billion.
Operating Cash Flow-57.74K
Free Cash Flow-57.74K
Free Cash Flow per Share>-0.01
Dividends & Yields
Stella Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change0.00%
50-Day Moving Average0.05
200-Day Moving Average0.05
Relative Strength Index (RSI)81.59
Average Volume (3m)7.00
Important Dates
Stella Diagnostics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Stella Diagnostics as a current ratio of <0.01, with Debt / Equity ratio of -36.09%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.38
Net Debt to EBITDA-5.37
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Stella Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Stella Diagnostics EV to EBITDA ratio is -19.35, with an EV/FCF ratio of -414.04.
EV to Sales0.00
EV to EBITDA-19.35
EV to Free Cash Flow-414.04
EV to Operating Cash Flow-414.08
Balance Sheet
Stella Diagnostics has $4.91K in cash and marketable securities with $6.64M in debt, giving a net cash position of $6.64M billion.
Cash & Marketable Securities$4.91K
Total Debt$6.64M
Net Cash$6.64M
Net Cash Per Share$0.07
Tangible Book Value Per Share-$0.05
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Stella Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―